Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mental health
Biotech
AbbVie in talks over $1B Gilgamesh buyout: report
AbbVie teamed up with Gilgamesh last year and is now reportedly in talks about buying the mental health biotech outright for about $1 billion.
Nick Paul Taylor
Jul 31, 2025 7:48am
Beckley Psytech psychedelic reduces depression symptoms in ph. 2
Jul 1, 2025 8:30am
Fierce Healthcare
Court blocks HHS RIF again after Trump's Supreme Court appeal
May 23, 2025 10:30am
JPM's private capital team ‘actively looking’ at psychedelics
Feb 28, 2024 7:00am
Cedars-Sinai adds AI-powered therapy app to Apple Vision Pro
Feb 5, 2024 12:00pm
FDA accepts first AI algorithm to drug development tool pilot
Jan 26, 2024 1:35pm